Elizabeth Phillips Archive
-
October 16, 2024
Study of severe drug reactions finds skin cells activate their own assassins
Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis. -
September 18, 2024
Clinic marks 10th year of diagnosis and treatment of drug allergies
The clinic, celebrating its 10th year, has seen groundbreaking discoveries in personalized care and diagnosis for allergy, especially delayed drug allergy, and has advanced discoveries in the optimal process to test patients for drug allergies. -
November 15, 2023
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. -
April 27, 2023
Phillips elected to Association of American Physicians
Vanderbilt's Elizabeth Phillips, MD, has been elected to membership in the Association of American Physicians -
September 29, 2022
Penicillin delabeling initiative expanding to more patient care areas
Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center. -
January 24, 2022
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children. -
August 12, 2021
Certain drug exposures correlate with reduced COVID severity: study
Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.